RBC Europe’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$0 Hold
16
﹤0.01% 651
2022
Q1
$1K Hold
16
﹤0.01% 617
2021
Q4
$1K Sell
16
-513
-97% -$28.4K ﹤0.01% 614
2021
Q3
$37.7K Hold
529
﹤0.01% 636
2021
Q2
$27.2K Hold
529
﹤0.01% 741
2021
Q1
$13.3K Buy
529
+500
+1,724% +$9.41K ﹤0.01% 861
2020
Q4
$348 Hold
29
﹤0.01% 1120
2020
Q3
$290 Sell
29
-1,036
-97% -$12.5K ﹤0.01% 1068
2020
Q2
$11.1K Sell
1,065
-9
-0.8% -$100 ﹤0.01% 748
2020
Q1
$11.5K Sell
1,074
-195
-15% -$2.36K ﹤0.01% 674
2019
Q4
$20.1K Hold
1,269
﹤0.01% 649
2019
Q3
$9.95K Hold
1,269
﹤0.01% 792
2019
Q2
$13.4K Hold
1,269
﹤0.01% 741
2019
Q1
$15.4K Hold
1,269
﹤0.01% 712
2018
Q4
$13.1K Hold
1,269
﹤0.01% 728
2018
Q3
$16.6K Hold
1,269
﹤0.01% 721
2018
Q2
$18.5K Buy
1,269
+936
+281% +$18.5K ﹤0.01% 693
2018
Q1
$12.2K Buy
333
+100
+43% +$3.64K ﹤0.01% 786
2017
Q4
$8.73K Sell
233
-100
-30% -$5.09K ﹤0.01% 862
2017
Q3
$21.6K Buy
+333
New +$20.4K ﹤0.01% 660

Other funds holding PRTA

RBC Europe's PRTA Position: Q2 2022 in Review

RBC Europe held its Prothena Corp (PRTA) position steady in Q2 2022 at 16 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #651.

RBC Europe first reported a position in PRTA in Q3 2017 and has held it in 20 quarters since. The position peaked at $37.7K in Q3 2021. 166 funds tracked by Wall St. Rank hold PRTA as of Q2 2022.

  • RBC Europe held 16 shares of Prothena Corp worth $0 as of Q2 2022.
  • RBC Europe left its Prothena Corp share count unchanged in Q2 2022.
  • Prothena Corp made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #651 holding.
  • RBC Europe first reported a position in Prothena Corp in Q3 2017 and has held it in 20 quarters since.
  • RBC Europe's Prothena Corp position peaked at $37.7K in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.